433 Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC)

Autor: Oudard, S., Benhamouda, N., Escudier, B., Ravel, P., Kothari, D., Mehmud, F., Levionnois, E., Sevin, E., Negrier, S., Barthelemy, P., Berdah, J.F., Ravaud, A., Sternberg, C.N., Bono, P., Porta, C., Giorgi, U. De, Parikh, O., Hawkins, R., Highley, M., Tartour, E., Decker, T., Wilkie, J.
Zdroj: In European Journal of Cancer September 2015 51 Supplement 3:S89-S90
Databáze: ScienceDirect
Externí odkaz: